Stefano Partelli

Stefano Partelli
专科:
移植外科 普通外科 - 急诊急救 胰腺外科
职业:
普外科医生
医疗机构:
胰腺外科 @ 圣拉斐尔科学研究医院
语言:
EN
IT

您需要预约吗？

联系我们，我们将为您妥善安排。
查看医生的可预约时间
发送请求

个人简介

Stefano Partelli 教授是 Vita-Salute San Raffaele 大学外科学副教授，同时任职于米兰 IRCCS Ospedale San Raffaele 胰腺外科及移植科，是该科室（由 Massimo Falconi 教授领导）的医生。

他于2004年毕业于维罗纳大学医学与外科专业，并于2010年获得普通外科专科资格，随后于2014年在维罗纳大学获得外科科学及肝胆胰疾病博士学位。在培训期间，他曾在多个国际知名机构开展科研及临床工作，包括英国 Royal London Hospital（Queen Mary University）、美国波士顿 Massachusetts General Hospital 以及纽约 Memorial Sloan-Kettering Cancer Center。2022年，他被任命为牛津移植中心（Churchill Hospital, 英国）的 Honorary Consultant，2025年担任多伦多大学 Sunnybrook 医院及德克萨斯大学 Southwestern 医学中心的访问教授。

在临床方面，Partelli 教授主要从事胰腺外科及移植外科，重点领域包括：

  • 胰腺肿瘤（腺癌、囊性及神经内分泌肿瘤）
  • 胰腺炎性疾病（急性及慢性胰腺炎）
  • 胆道良恶性疾病（胆结石、胆管癌）
  • 神经内分泌肿瘤（肠胰及肾上腺）
  • 腹壁疾病（疝及切口疝）
  • 肾移植
  • 肾—胰联合移植。

他的手术经验包括超过1000例普通外科手术，其中包括400余例胰腺切除手术，部分结合血管重建及腹腔镜技术完成。

他常规开展多种微创手术，包括：

  • 远端胰腺切除术（伴或不伴脾切除），
  • 胰腺肿瘤剜除术，
  • 中段胰腺切除术，
  • 胆囊切除术，
  • 肾上腺切除术。

他还是神经内分泌肿瘤多学科团队成员，该团队自2019年起被认证为 ENETS 卓越中心，并由他负责协调外科工作。

在科研方面，Partelli 教授是多项前瞻性临床研究的主要研究者或协调者，包括 ASPEN、Neo.Lu.Pa.NET、BioSteP 和 FIRENEN，并作为特邀讲者在超过100场国内外学术会议上发表成果。

他已发表超过290篇学术论文（包括原创研究、综述及评论），均被 PubMed 收录，h指数为52，总引用次数超过9700次（Scopus，2025年8月）。

他是多个国际学术学会成员，包括 ENETS、ESSO、ESOT、E-AHPBA、EPC、SIC、AISP 和 It.a.NET，并在多个国际科学及教育委员会中担任职务。

多媒体中心

Neuroendocrine tumors: what they are, how to recognize them, and how they are treated

出版物

最新出版物

Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting
Surg Endosc. 2020 Jan 17. doi: 10.1007/s00464-020-07375-0. [Epub ahead of print] PubMed PMID: 31953734.
Partelli S, Andreasi V, Rancoita PMV, Perez-Sanchez E, Muffatti F, Balzano G, Crippa S, Di Serio C, Falconi M.
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens
Neuroendocrinology. 2019;109(2):165-170. doi: 10.1159/000499606. Epub 2019 May 22. PubMed PMID: 31117106.
Partelli S, Giannone F, Schiavo Lena M,Muffatti F, Andreasi V, Crippa S, Tamburrino D, Zamboni G, Rubini C, Doglioni C, Falconi M.
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life
Surgery. 2019 Aug;166(2):157-163. doi: 10.1016/j.surg.2019.04.003. Epub 2019 May 17. PubMed PMID: 31109657.
Partelli S, Mazza M, Andreasi V, Muffatti F, Crippa S, Tamburrino D, Falconi M.
Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma
Pancreas. 2019 Apr;48(4):504-509. doi: 10.1097/MPA.0000000000001273. PubMed PMID: 30946244.
Partelli S, Tamburrino D, Cherif R, Muffatti F, Moggia E, Gaujoux S, Sauvanet A, Falconi M, Fusai G.
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age
Dig Liver Dis. 2019 May;51(5):735-740. doi: 10.1016/j.dld.2019.01.008. Epub 2019 Jan 22. PubMed PMID: 30723019.
Partelli S, Muffatti F, Rancoita PMV, Andreasi V, Balzano G, Crippa S, Doglioni C, Rubini C, Zamboni G, Falconi M.
The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms
Eur J Surg Oncol. 2018 Jun;44(6):778-783. doi: 10.1016/j.ejso.2018.03.005. Epub 2018 Mar 17. PubMed PMID: 29610023.
Partelli S, Javed AA, Andreasi V, He J, Muffatti F, Weiss MJ, Sessa F, La Rosa S, Doglioni C, Zamboni G, Wolfgang CL, Falconi M.
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms
Surgery. 2018 Apr;163(4):761-767. doi: 10.1016/j.surg.2017.11.007. Epub 2017 Dec 25. PubMed PMID: 29284590.
Partelli S, Bertani E, Bartolomei M, Perali C, Muffatti F, Grana CM, Schiavo Lena M, Doglioni C, Crippa S, Fazio N, Zamboni G, Falconi M.
Early Postoperative Prediction of Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy: usefulness of C-reactive Protein
HPB (Oxford). 2017 Jul;19(7):580-586. doi: 10.1016/j.hpb.2017.03.001. Epub 2017 Apr 7. PubMed PMID: 28392159.
Partelli S, Pecorelli N, Muffatti F, Belfiori G, Crippa S, Piazzai F, Castoldi R, Marmorale C, Balzano G, Falconi M.
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours
Neuroendocrinology. 2017;105(3):255-265. doi: 10.1159/000464292. Epub 2017 Feb 25. PubMed PMID: 28237989.
Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, Nieveen van Dijkum EJM, Pape UF, Pascher A, Ramage J, Reed N, Ruszniewski P, Scoazec JY, Toumpanakis C, Kianmanesh R, Falconi M; Antibes Consensus Conference participants.
Whole-genome landscape of pancreatic neuroendocrine tumours
Nature. 2017 Mar 2;543(7643):65-71. doi: 10.1038/nature21063. Epub 2017 Feb 15. Erratum in: Nature. 2017 Sep 27;:. PubMed PMID: 28199314.
58: Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Davì MV, Landoni L, Malpaga A, Miotto M, Whitehall VL, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras MC, Fisher WE, Dagg RA, Lau LM, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M; Australian Pancreatic Cancer Genome Initiative, Khanna KK, Gill AJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM.
Evaluation of an enhanced recovery protocol after pancreaticoduodenectomy in elderly patients
HPB (Oxford). 2016 Feb;18(2):153-158. doi: 10.1016/j.hpb.2015.09.009. Epub 2015 Dec 10. PubMed PMID: 26902134; PubMed Central PMCID: PMC4814589.
Partelli S, Cirocchi R, Crippa S, Cardinali L, Fendrich V, Bartsch DK, Falconi M. Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms. Br J Surg. 2017 Jan;104(1):34-41. doi: 10.1002/bjs.10312. Epub 2016 Oct 5. Review. PubMed PMID: 27706803. Partelli S, Crippa S, Castagnani R, Ruffo G, Marmorale C, Franconi AM, De Angelis C, Falconi M.
Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs)
JAMA Surg. 2013 Oct;148(10):932-9. doi: 10.1001/jamasurg.2013.3376. PubMed PMID: 23986355.
Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, Scarpa A, Ruszniewski P, Sauvanet A, Falconi M.
Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection
Ann Surg Oncol. 2011 Dec;18(13):3608-14. doi: 10.1245/s10434-011-1769-1. Epub 2011 May 17. PubMed PMID: 21584836.
Partelli S, Crippa S, Barugola G, Tamburrino D, Capelli P, D'Onofrio M, Pederzoli P, Falconi M.
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio
Ann Surg. 2010 Mar;251(3):477-82. doi: 10.1097/SLA.0b013e3181cf9155. PubMed PMID: 20142730; PubMed Central PMCID: PMC3135381.
Partelli S, Fernandez-Del Castillo C, Bassi C, Mantovani W, Thayer SP, Crippa S, Ferrone CR, Falconi M, Pederzoli P, Warshaw AL, Salvia R.